Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42697203
GLP-1 agonists, approved for metabolic conditions, may benefit cardiology patients with obesity or type 2 diabetes, offering new therapeutic options.
GLP-1 agonists, including FDA-approved resmetirom and semaglutide, are studied for metabolic conditions, potentially benefiting cardiology patients with obesity or type 2 diabetes.
What Do We Know About Pain Pathways in Diabetic Peripheral Neuropathy? A Contemporary Narrative Review. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42660716
Explore metabolic and neuroimmune interactions on CNS plasticity in diabetic neuropathy, focusing on nociceptor sensitization and pain signaling for individualized therapies.
Explore metabolic and neuroimmune interactions affecting CNS plasticity in diabetic neuropathy, focusing on nociceptor sensitization and pain signaling for individualized therapies.
Microbial metabolite-driven mechanisms linking the gut microbiome to atherosclerosis: multi-omic and translational perspectives. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42615833
Explore how gut microbiome metabolites like imidazole propionate influence atherosclerosis through vascular inflammation and plaque development, focusing on specific signaling pathways.
Gut microbiome metabolites, such as trimethylamine oxide, contribute to atherosclerosis via macrophage lipid accumulation and mTORC1 signaling activation. Disease Condition: Atherosclerosis. Specialty Focus: Cardiology.
The effect of ascorbic acid supplementation on plasma leptin and adiponectin levels: Systematic review of and studies. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42592588
Explore the impact of ascorbic acid on adiponectin and leptin levels, with varying results in human studies.
Ascorbic acid supplementation may increase adiponectin levels and potentially reduce leptin levels, though human study results present conflicting evidence regarding the effect on leptin levels.
A three-metabolite microbiota-associated signature for early risk stratification of gestational diabetes mellitus. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42568080
Explore a microbiota-associated metabolic signature for early gestational diabetes risk stratification, offering insights into pregnancy-related cardiometabolic risk.
A three-metabolite microbiota signature, including 3-hydroxydecanoic acid, γ-Glu-Leu, and propionic acid, aids early gestational diabetes risk stratification. Specialty Focus: Endocrinology.